Conclusion
Co-trimoxazole administration was associated with an increased risk of
hyperkalemia especially among older patients and those receiving other
co-administered medications that may induce hyperkalemia. Caution should
be exercised when co-trimoxazole is used in older people and patients
receiving other medications affecting potassium levels such as
immunosuppressants and the combination of an immunosuppressant and
β-blocker.